In her own research, Dr. Weigel has investigated the role of cell signaling in progesterone receptor action, coactivators and androgen receptors in prostate cancer, as well as the role of vitamin D receptors in prostate cancer target genes. In the last 3 years, Dr. Weigel has completed studies including analysis of the role of androgen receptor splice variants in castration resistant prostate cancer, the regulation of progesterone receptors by phosphorylation, and TMPRSS2-ERG gene fusions and vitamin D action in prostate cancer, among others.
Dr. Weigel brings a wide breadth of knowledge and editorial experience to Hormones and Cancer that will facilitate continued excellence and future growth. At the end of her 3 year term, Dr. Weigel's goal for Hormones and Cancer is to have developed it into a journal that authors think of as one of the first possibilities for submission in this area, particularly when their studies contain components of basic science and more translational research including analyses of clinical data.
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